Larvol Delta - SUMITELA-A-Study-of-Samuraciclib-and-Elacestrant-in-Participants-With-Metastatic-or-Locally-Advanced-HRHER2negative-Breast-Cancer

Orserdu (elacestrant) - Menarini

samuraciclib (CT7001) - Carrick Therap

http://clinicaltrials.gov/ct2/show/NCT05963997

Sep 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next